In CRC, elevated PGC-1α promotes glucose uptake and lipid synthesis to fuel rapid cell proliferation and increases oxidative metabolism, thereby fostering chemoresistance [43]; its over-expression correlates with advanced lymph-node stage and poorer prognosis, making it a strong indicator of shortened survival [42]. The gene discussed is PPARGC1A; the disease is colorectal carcinoma.